FGF21 and amyotrophic lateral sclerosis: Moreover, in an amyotrophic lateral sclerosis (ALS) model, the activation of the FGF21 signaling pathway slowed the onset of ALS by regulating the exercise capacity, metabolic status, and inflammation levels of mice [60].